Plk Polyclonal Antibody

The Ser/Thr protein kinase encoded by this gene belongs to the CDC5/Polo subfamily. It is highly expressed during mitosis and elevated levels are found in many different types of cancer. Depletion of this protein in cancer cells dramatically inhibited cell proliferation and induced apoptosis; hence, it is a target for cancer therapy.

The Plk Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of Polo-like kinase (Plk) protein expression in various biological samples. This antibody is produced using advanced recombinant DNA technology, ensuring high purity and batch-to-batch consistency.

The Plk Polyclonal Antibody exhibits exceptional affinity and selectivity towards Plk, enabling accurate and reliable results in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting applications. Its superior sensitivity allows for the detection of low levels of Plk protein, making it an ideal choice for both qualitative and quantitative analysis.

This antibody is validated for use in multiple species, including human, mouse, and rat, ensuring its versatility and applicability across a wide range of research areas. Its robust performance and consistent performance make it an indispensable tool for studying Plk protein function, cellular processes, and disease mechanisms.

The Plk Polyclonal Antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and complex preparation steps. It is provided in a liquid formulation, allowing for easy handling and minimizing the risk of sample contamination.

With its exceptional specificity, sensitivity, and ease of use, the Plk Polyclonal Antibody is an essential tool for researchers and scientists involved in molecular biology, cell biology, cancer research, and drug discovery. It offers reliable and reproducible results, enabling accurate data interpretation and facilitating advancements in scientific knowledge and understanding.